Ahmed M Hamdan
Overview
Explore the profile of Ahmed M Hamdan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassan H, Hamdan A, Alattar A, Alshaman R, Bahattab O, Al-Gayyar M
Redox Rep
. 2024 Jun;
29(1):2365590.
PMID: 38861483
Emodin is a naturally occurring anthraquinone derivative with a wide range of pharmacological activities, including neuroprotective and anti-inflammatory activities. We aim to assess the anticancer activity of emodin against hepatocellular...
2.
Hassan Y, El-Shiekh R, El Hefnawy H, Mohamed O, Abu-Elfotuh K, Hamdan A, et al.
J Ethnopharmacol
. 2024 Jan;
324:117747.
PMID: 38218500
Ethnopharmacological Relevance: Irvingia gabonensis (Aubry-Lecomte ex O'Rorke) Baill., also known as "African mango" or "bush mango", belonging to family Irvingiaceae, has been mostly used as food and traditional medicine for...
3.
Al-Gayyar M, Alattar A, Alshaman R, Hamdan A
Cytokine
. 2021 Sep;
148:155710.
PMID: 34564023
The pathogenicity of HCC could be enhanced by TNF-α and NFκB, which are crucial parts of the inflammatory pathway inside the HCC microenvironment. Therefore, we aimed to discover the therapeutic...
4.
Hassan H, M H El-Kannishy S, Alattar A, Alshaman R, Hamdan A, Al-Gayyar M
Biomed Pharmacother
. 2021 Jan;
135:111216.
PMID: 33433352
Destructive effects of hepatocellular carcinoma (HCC) is enhanced by many cellular mechanisms including activation of fibrosis, inflammation and tumor invasion. Therefore, this study was conducted to investigate the therapeutic effects...
5.
AlKharboush H, Alshehri F, Alatwi I, Al Karni K, Alatawi A, Hamdan A
Cureus
. 2021 Jan;
12(12):e11895.
PMID: 33415047
Background and objective Anemia is a common prognosis of chronic kidney disease (CKD). It is predominantly managed with synthetic erythropoietin. The principal objective of this study was to compare the...
6.
Faisal W, Soliman G, Hamdan A
J Liposome Res
. 2016 Sep;
28(1):14-21.
PMID: 27667097
Despite its broad-spectrum antifungal properties, voriconazole has many side effects when administered systemically. The aim of this work was to develop an ethosomal topical delivery system for voriconazole and test...
7.
Al-Gayyar M, Abbas A, Hamdan A
Biol Chem
. 2016 Jan;
397(3):257-67.
PMID: 26733159
Sulfatase 2 (SULF2) is an extracellular enzyme that catalyzes the removal of 6-O-sulfate groups from the heparan sulfate (HS). As elevated SULF2 activity has been correlated with hepatocellular carcinoma (HCC),...
8.
Al-Gayyar M, Alyoussef A, Hamdan A, Abbas A, Darweish M, El-Hawwary A
Life Sci
. 2014 Dec;
120:13-21.
PMID: 25447450
Aims: Sodium nitrite is used to inhibit the growth of microorganisms and is responsible for the desirable red color of meat; however, it can be toxic in high quantities for...
9.
El-Habashy S, Nazief A, Adkins C, Wen M, El-Kamel A, Hamdan A, et al.
Pharm Pat Anal
. 2014 Jul;
3(3):279-96.
PMID: 24998288
This review summarizes patent applications in the past 5 years for the management of brain tumors and metastases. Most of the recent patents discuss one of the following strategies: the...
10.
Horiguchi M, Koyanagi S, Hamdan A, Kakimoto K, Matsunaga N, Yamashita C, et al.
Cancer Res
. 2013 Apr;
73(8):2639-49.
PMID: 23580573
The sensitivity of cancer cells to chemotherapeutic agents varies according to circadian time. Most chemotherapeutic agents ultimately cause cell death through cell-intrinsic pathways as an indirect consequence of DNA damage....